INSIGHTS ON CLINICAL TRIAL DESIGN
-
Bringing Intelligence Into The Flow Of Clinical Trials
AI-driven trial intelligence turns complex data into real-time insight, enabling earlier risk detection, stronger oversight, and smarter decisions across the trial lifecycle.
-
Optimizing Movement Disorder Clinical Trials: A Focus On Parkinson's Disease
Join DVCR experts for a presentation on designing effective Parkinson's clinical trials. This webinar covers endpoint selection, patient-centered design, and real-world case studies.
-
Traditional, Hybrid Or Decentralized: What Actually Works?
Learn how traditional, decentralized, and community-based approaches address different study challenges and support more effective, patient-centered research.
-
On-Demand Service Models Improve Clinical Trials
As consumers increasingly expect convenience and immediacy, the on-demand model continues to reshape how services are delivered across nearly every sector.
-
Next-Generation ADC Trials – Turning Complexity Into Execution7/20/2026
As ADC science advances, operational strategy becomes critical. Learn how smarter protocol design, real-time monitoring and collaborative execution can accelerate next-generation ADC trials.
-
Why Tax Reporting Matters In Clinical Trial Participant Payments3/20/2026
Clinical trial participant payments can trigger often overlooked tax reporting obligations. Learn why early visibility into payments matters and how better tracking helps avoid compliance surprises.
-
Making Early Decisions In Psychiatric Drug Development7/30/2026
Quantitative PD measures provide objective evidence of target engagement, support dose selection, strengthen early go/no-go decisions, and help reduce development risk in psychiatric
-
Ophthalmology Patient Engagement And Retention: Point-Of-Need Execution4/6/2026
Dropout in retinal trials is often a logistical failure. Reducing travel burden and bringing specialized care to the patient can slash attrition rates and secure critical trial timelines.
-
Running Decentralized Trials At Scale5/8/2026
Sponsors are recognizing the potential benefits of decentralized clinical trials, including reduced operational costs and improved recruitment and retention of more diverse patient populations.
CLINICAL TRIAL DESIGN SOLUTIONS
-
With a single, consistent team from FIH to Proof-of-Concept, this Continuity Model eliminates fragmented handoffs to keep program knowledge intact and speed your path to Phase II.
-
Accelerate study start-up with the right sites, patients, and partnerships
As protocols become more complex and sites face new pressures, your site selection strategy needs to be more nuanced than ever before. At Parexel, we bring that nuance and precision with the help of our Site Alliance Strategists, Community Alliance Network and Launch Excellence Office — a team who are committed to launching your projects quickly and efficiently with expertise in all key functions in clinical development strategy, planning, oversight, and delivery execution.
-
Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
-
Built on a globally compliant platform, explore a suite of technologies and services that sits at the crossroads of sponsors, recruitment partners, patients, HCPs, and trial sites.
-
Altasciences provides deep expertise in all clinical pharmacology studies required for successful regulatory submission across a wide range of therapeutic areas.
View the complete resource library.
Contact an Altasciences expert to learn more about their comprehensive clinical solution.